Kontafarma China Holdings Limited (1312.HK)

0.038 +0.003 (+8.57%) As of 09:53AM HKT. Market open.

Kontafarma China Holdings Limited

Sun Hung Kai Centre
12A/F, Room 12A09–12A20 30 Harbour Road
Wan Chai
Hong Kong
852 2731 6500
https://www.kontafarma.com.hk

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 720

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Pingyan Bai	Executive Chairman	N/A	N/A	1971
Mr. Chaowen Jiang	VP, CEO & Executive Director	3.36M	N/A	1965
Mr. Hongjie Chai	Executive Director	N/A	N/A	1973
Ms. Man Wai Si Tou	VP, CFO & Company Secretary	N/A	N/A	1978
Mr. Jie Zhang	VP & COO	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.

Description

Kontafarma China Holdings Limited, an investment holding company, engages in the manufacture and sale of prescription drugs in Mainland China, Singapore, Taiwan, and internationally. It operates in Pharmaceutical Business and Fitness Business segments. The company offers chemical drugs and prescribed traditional Chinese medicines; operates fitness and yoga centers; operates in the franchise business; and provides consultation services for fitness and health activities. It also researches and develops medical products; and offers corporate advisory services. The company was formerly known as Tongfang Kontafarma Holdings Limited and changed its name to Kontafarma China Holdings Limited in September 2022. The company was founded in 1993 and is headquartered in Wan Chai, Hong Kong. Kontafarma China Holdings Limited is a subsidiary of China Health Management Investment Limited.

Corporate governance

Kontafarma China Holdings Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.